KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 0.17.

  • Medpace Holdings' Equity Ratio fell 6039.5% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year decrease of 6039.5%. This contributed to the annual value of 0.39 for FY2024, which is 1647.88% up from last year.
  • Latest data reveals that Medpace Holdings reported Equity Ratio of 0.17 as of Q3 2025, which was down 6039.5% from 0.11 recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Equity Ratio registered a high of 0.59 during Q1 2021, and its lowest value of 0.11 during Q2 2025.
  • Over the past 5 years, Medpace Holdings' median Equity Ratio value was 0.34 (recorded in 2023), while the average stood at 0.36.
  • Per our database at Business Quant, Medpace Holdings' Equity Ratio surged by 5030.03% in 2024 and then plummeted by 7242.61% in 2025.
  • Over the past 5 years, Medpace Holdings' Equity Ratio (Quarter) stood at 0.57 in 2021, then crashed by 50.24% to 0.29 in 2022, then increased by 18.09% to 0.34 in 2023, then increased by 16.48% to 0.39 in 2024, then tumbled by 57.37% to 0.17 in 2025.
  • Its Equity Ratio stands at 0.17 for Q3 2025, versus 0.11 for Q2 2025 and 0.31 for Q1 2025.